Quality Measures for 2008 PQRI
The 119 quality measures included in the 2008 PQRI program are listed below. The measures are sorted alphabetically by disease/condition. For each measure that you feel might be applicable to your practice, click on any of the three PDF documents listed to the right of the measure for additional information.
(an * indicates that a document has been revised since the initial posting)
View release notes for a list of technical corrections since initial posting
| Quality Measures Acute Bronchitis #116. Inappropriate antibiotic treatment for adults with acute bronchitis Measure Description Data Collection Sheet * Coding Specifications Acute Myocardial Infarction #28. Aspirin at arrival for acute myocardial infarction (AMI) Measure Description Data Collection Sheet Coding Specifications Acute Otitis Externa (AOE) #91. Topical therapy Measure Description Data Collection Sheet Coding Specifications #92. Pain assessment Measure Description Data Collection Sheet Coding Specifications #93. Systemic antimicrobial therapy – avoidance of inappropriate use Measure Description Data Collection Sheet Coding Specifications Asthma #53. Pharmacologic therapy Measure Description Data Collection Sheet Coding Specifications #64. Asthma assessment Measure Description Data Collection Sheet Coding Specifications Cancer Non-Specific #73. Plan for chemotherapy documented before chemotherapy administered Measure Description Data Collection Sheet Coding Specifications Breast Cancer #71. Hormonal therapy for stage IC-III, ER/PR positive breast cancer Measure Description Data Collection Sheet * Coding Specifications #74. Radiation therapy recommended for invasive breast cancer patients who have undergone breast conserving surgery Measure Description Data Collection Sheet Coding Specifications Chronic Lymphocytic Leukemia #70. Baseline flow cytometry Measure Description Data Collection Sheet Coding Specifications Colon Cancer #72. Chemotherapy for stage III colon cancer patients Measure Description Data Collection Sheet Coding Specifications Multiple Myeloma #69. Treatment with bisphosphonates Measure Description Data Collection Sheet Coding Specifications Myelodysplastic Syndrome (MDS) #68. Documentation of iron stores in patients receiving erythropoietin therapy Measure Description Data Collection Sheet Coding Specifications Myelodysplastic Syndrome (MDS) & Acute Leukemias #67. Baseline cytogenetic testing performed on bone marrow Measure Description Data Collection Sheet Coding Specifications Prostate Cancer #101. Appropriate initial evaluation of patients with prostate cancer Measure Description Data Collection Sheet Coding Specifications #102. Inappropriate use of bone scan for staging low-risk prostate cancer patients Measure Description Data Collection Sheet Coding Specifications #103. Review of treatment options in patients with clinically localized prostate cancer Measure Description Data Collection Sheet Coding Specifications #104. Adjuvant hormonal therapy for high-risk prostate cancer patients Measure Description Data Collection Sheet Coding Specifications #105. Three-dimensional radiotherapy for patients with prostate cancer Measure Description Data Collection Sheet Coding Specifications Chest Pain (Non-traumatic) #54. Electrocardiogram performed for non-traumatic chest pain Measure Description Data Collection Sheet Coding Specifications Chronic Kidney Disease (CKD) #120. ACE inhibitor or Angiotensin Receptor Blocker (ARB) therapy in patients with CKD Measure Description Data Collection Sheet Coding Specifications #121. Laboratory testing (calcium, phosphorus, intact parathyroid hormone (iPTH) and lipid profile) Measure Description Data Collection Sheet Coding Specifications #122. Blood pressure management Measure Description Data Collection Sheet Coding Specifications #123. Plan of care - elevated hemoglobin for patients receiving erythropoiesis-stimulating agents (ESA) Measure Description Data Collection Sheet Coding Specifications Chronic Obstructive Pulmonary Disease (COPD) #51. Spirometry evaluation Measure Description Data Collection Sheet Coding Specifications #52. Bronchodilator therapy Measure Description Data Collection Sheet Coding Specifications Community-Acquired Bacterial Pneumonia #56. Vital signs for community-acquired bacterial pneumonia Measure Description Data Collection Sheet Coding Specifications #57. Assessment of oxygen saturation for community-acquired bacterial pneumonia Measure Description Data Collection Sheet Coding Specifications #58. Assessment of mental status for community-acquired bacterial pneumonia Measure Description Data Collection Sheet Coding Specifications #59. Empiric antibiotic for community acquired-bacterial pneumonia Measure Description Data Collection Sheet Coding Specifications Coronary Artery Disease #06. Oral antiplatelet therapy prescribed for patients with coronary artery disease Measure Description Data Collection Sheet Coding Specifications #07. Beta-blocker therapy for coronary artery disease patients with prior myocardial infarction Measure Description Data Collection Sheet Coding Specifications #118. Angiotensin converting enzyme inhibitor (ACE) or angiotensin receptor blocker (ARB) therapy for patients with coronary artery disease and diabetes and/or left ventricular systolic dysfunction (LVSD) Measure Description Data Collection Sheet Coding Specifications Critical Care #75. Prevention of ventilator-associated pneumonia – head elevation Measure Description Data Collection Sheet Coding Specifications #76. Prevention of catheter-related bloodstream infections (CRBSI) – central venous catheter insertion protocol Measure Description Data Collection Sheet Coding Specifications Depression – Major Depressive Disorder #09. Antidepressant medication during acute phase for patients with new episode disease of major depression Measure Description Data Collection Sheet Coding Specifications #106. Patients who have major depression disorder who meet DSM IV criteria Measure Description Data Collection Sheet Coding Specifications #107. Patients who have major depression disorder who are assessed for suicide risks Measure Description Data Collection Sheet Coding Specifications Diabetes Mellitus #01. Hemoglobin A1c poor control in Type 1 or 2 diabetes mellitus Measure Description Data Collection Sheet Coding Specifications #02. Low density lipoprotein control in Type 1 or 2 diabetes mellitus Measure Description Data Collection Sheet Coding Specifications #03. High blood pressure control in Type 1 or 2 diabetes mellitus Measure Description Data Collection Sheet Coding Specifications * #117. Dilated eye exam in diabetic patient Measure Description Data Collection Sheet Coding Specifications #119. Urine screening for microalbumin or medical attention for nephropathy in diabetic patients Measure Description Data Collection Sheet Coding Specifications #126. Diabetic foot and ankle care, peripheral neuropathy: neurological evaluation Measure Description Data Collection Sheet Coding Specifications #127. Diabetic foot and ankle care, ulcer prevention: evaluation of footwear Measure Description Data Collection Sheet Coding Specifications End Stage Renal Disease (ESRD) #78. Vascular access for patients undergoing hemodialysis Measure Description Data Collection Sheet * Coding Specifications #79. Influenza vaccination in patients with end stage renal disease Measure Description Data Collection Sheet Coding Specifications #80. Plan of care for ESRD patients with anemia Measure Description Data Collection Sheet Coding Specifications #81. Plan of care for inadequate hemodialysis in ESRD patients Measure Description Data Collection Sheet * Coding Specifications #82. Plan of care for inadequate peritoneal dialysis Measure Description Data Collection Sheet Coding Specifications Eye Care Age-Related Macular Degeneration #14. Dilated macular examination Measure Description Data Collection Sheet Coding Specifications * Diabetic Retinopathy #18. Documentation of presence or absence of macular edema and level of severity of retinopathy Measure Description Data Collection Sheet Coding Specifications #19. Communication with the physician managing ongoing diabetes care Measure Description Data Collection Sheet Coding Specifications Primary Open Angle Glaucoma #12. Optic nerve evaluation Measure Description Data Collection Sheet Coding Specifications Gastroesophageal Reflux Disease (GERD) #77. Assessment of GERD symptoms in patients receiving chronic medication for GERD Measure Description Data Collection Sheet * Coding Specifications Geriatric Care #04. Screening for future fall risk Measure Description Data Collection Sheet Coding Specifications #46. Medication reconciliation Measure Description Data Collection Sheet Coding Specifications #47. Advance care plan Measure Description Data Collection Sheet Coding Specifications Health Information Technology (Health IT) #124. Adoption/use of health information technology (electronic health records) Measure Description Data Collection Sheet Coding Specifications #125. Adoption/use of e-prescribing Measure Description Data Collection Sheet Coding Specifications Heart Failure #05. Angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) therapy for left ventricular systolic dysfunction (LVSD) Measure Description Data Collection Sheet Coding Specifications #08. Beta-blocker therapy for left ventricular systolic dysfunction Measure Description Data Collection Sheet Coding Specifications Hepatitis C #83. Testing of patients with chronic hepatitis C (HCV) for hepatitis C viremia Measure Description Data Collection Sheet Coding Specifications #84. Initial hepatitis C RNA testing Measure Description Data Collection Sheet Coding Specifications #85. HCV genotype testing prior to therapy Measure Description Data Collection Sheet Coding Specifications #86. Consideration for antiviral therapy in HCV patients Measure Description Data Collection Sheet Coding Specifications #87. HCV RNA testing at week 12 of therapy Measure Description Data Collection Sheet Coding Specifications #88. Hepatitis A and B vaccination in patients with HCV Measure Description Data Collection Sheet Coding Specifications #89. Counseling patients with HCV regarding use of alcohol Measure Description Data Collection Sheet Coding Specifications #90. Counseling of patients regarding use of contraception prior to starting antiviral therapy Measure Description Data Collection Sheet Coding Specifications Osteoarthritis #109. Patients with osteoarthritis who have an assessment of their pain and function Measure Description Data Collection Sheet Coding Specifications * Osteoporosis #24. Communication with the physician managing ongoing care post-fracture Measure Description Data Collection Sheet Coding Specifications #39. Screening or therapy for osteoporosis for women aged 65 years and older Measure Description Data Collection Sheet Coding Specifications #40. Management following fracture Measure Description Data Collection Sheet Coding Specifications #41. Pharmacologic therapy Measure Description Data Collection Sheet Coding Specifications Otitis Media with Effusion (OME) #94. Diagnostic evaluation – assessment of tympanic membrane mobility Measure Description Data Collection Sheet Coding Specifications #95. Hearing testing Measure Description Data Collection Sheet Coding Specifications #96. Antihistamines or decongestants – avoidance of inappropriate use Measure Description Data Collection Sheet Coding Specifications #97. Systemic antimicrobials – avoidance of inappropriate use Measure Description Data Collection Sheet Coding Specifications #98. Systemic corticosteroids – avoidance of inappropriate use Measure Description Data Collection Sheet Coding Specifications Pathology #99. Breast cancer patients who have a pT and pN category and histologic grade for their cancer Measure Description Data Collection Sheet Coding Specifications #100. Colorectal cancer patients who have a pT and pN category and histologic grade for their cancer Measure Description Data Collection Sheet Coding Specifications Perioperative Care #20. Timing of antibiotic prophylaxis - Ordering physician Measure Description * Data Collection Sheet * Coding Specifications #21. Selection of prophylactic antibiotic - First OR second generation cephalosporin Measure Description * Data Collection Sheet * Coding Specifications #22. Discontinuation of prophylactic antibiotics (Non-cardiac procedures) Measure Description * Data Collection Sheet * Coding Specifications #23. Venous thromboembolism (VTE) prophylaxis (When indicated in ALL patients) Measure Description * Data Collection Sheet * Coding Specifications #30. Timing of prophylactic antibiotics - Administering physician Measure Description * Data Collection Sheet * Coding Specifications #45. Discontinuation of prophylactic antibiotics (Cardiac procedures) Measure Description * Data Collection Sheet * Coding Specifications Coronary Artery Bypass Graft (CABG) #43. Use of internal mammary artery (IMA) in CABG surgery Measure Description Data Collection Sheet Coding Specifications #44. Pre-operative beta-blocker in patients with isolated CABG surgery Measure Description Data Collection Sheet Coding Specifications Preventive Care and Screening #110. Influenza vaccination for patients ≥ 50 years old Measure Description Data Collection Sheet Coding Specifications #111. Pneumonia vaccination for patients 65 years and older Measure Description Data Collection Sheet Coding Specifications #112. Screening mammography Measure Description Data Collection Sheet Coding Specifications #113. Colorectal cancer screening Measure Description Data Collection Sheet Coding Specifications #114. Inquiry regarding tobacco use Measure Description Data Collection Sheet Coding Specifications #115. Advising smokers to quit Measure Description Data Collection Sheet Coding Specifications Pharyngitis #66. Appropriate testing for children with pharyngitis Measure Description Data Collection Sheet Coding Specifications Rheumatoid Arthritis #108. Disease modifying anti-rheumatic drug therapy in rheumatoid arthritis Measure Description Data Collection Sheet Coding Specifications Stroke and Stroke Rehabilitation #31. Deep vein thrombosis (DVT) prophylaxis for ischemic stroke or intracranial hemorrhage Measure Description Data Collection Sheet Coding Specifications * #32. Discharged on antiplatelet therapy Measure Description Data Collection Sheet Coding Specifications * #33. Anticoagulant therapy prescribed for atrial fibrillation at discharge Measure Description Data Collection Sheet Coding Specifications * #34. Tissue plasminogen activator (t-PA) considered Measure Description Data Collection Sheet Coding Specifications * #35. Screening for dysphagia Measure Description Data Collection Sheet Coding Specifications * #36. Consideration of rehabilitation services Measure Description Data Collection Sheet Coding Specifications * Stroke and Stroke Rehabilitation - Radiology #10. Computed tomography (CT) or magnetic resonance imaging (MRI) reports Measure Description Data Collection Sheet Coding Specifications #11. Carotid imaging reports Measure Description Data Collection Sheet Coding Specifications Syncope #55. Electrocardiogram performed for syncope Measure Description Data Collection Sheet Coding Specifications Upper Respiratory Infection (URI) #65. Appropriate treatment for children with upper respiratory infection Measure Description Data Collection Sheet Coding Specifications Urinary Incontinence #48. Assessment of presence or absence of urinary incontinence in women aged 65 years and older Measure Description Data Collection Sheet Coding Specifications #49. Characterization of urinary incontinence in women aged 65 years and older Measure Description Data Collection Sheet Coding Specifications #50. Plan of care for urinary incontinence in women aged 65 years and older Measure Description Data Collection Sheet Coding Specifications Measures Applicable to Health Care Professionals Other than MD/DO Physicians #128. Universal weight screening and follow-up Measure Description Data Collection Sheet Coding Specifications #129. Universal influenza vaccine screening and counseling Measure Description Data Collection Sheet Coding Specifications #130. Universal documentation and verification of current medications in the medical record Measure Description * Data Collection Sheet Coding Specifications #131. Pain assessment prior to initiation of patient treatment Measure Description Data Collection Sheet Coding Specifications #132. Patient co-development of treatment plan/plan of care Measure Description Data Collection Sheet Coding Specifications #133. Screening for cognitive impairment Measure Description Data Collection Sheet Coding Specifications #134. Screening for clinical depression Measure Description Data Collection Sheet Coding Specifications |
Many of the measures in the PQRI were developed by the AMA-convened Physician Consortium for Performance Improvement®, in collaboration with the National Committee for Quality Assurance (NCQA) and/or a medical specialty society. For additional information on the Consortium including additional background information on the quality measures with both the rationale and evidence base for each measure, please visit www.physicianconsortium.org.
For additional information on NCQA and NCQA measures, please visit www.ncqa.org.
Questions: For additional information on the PQRI program, please visit the CMS Web site at http://www.cms.hhs.gov/pqri.
